Published in Osteoporos Int on January 01, 1997
How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Physician (2003) 2.42
Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int (2009) 1.12
Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women. Osteoporos Int (2003) 0.92
A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service. Osteoporos Int (2004) 0.90
Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England. Osteoporos Int (2003) 0.83
Predictors of Ibandronate Efficacy for the Management of Osteoporosis: A Meta-Regression Analysis. PLoS One (2016) 0.75
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol (1992) 1.74
Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol Reprod Biol (1995) 1.45
Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol (1995) 0.97
Guidelines for bone densitometry. Med J Aust (1994) 0.86
The prevalence of oestrogen replacement therapy in South Australia. Maturitas (1993) 0.81
Effects of continuous low-dosage hormonal replacement therapy on lipoprotein metabolism in postmenopausal women. Metabolism (1995) 0.76
Treatment options for osteoporosis. Mayo Clin Proc (1995) 0.76
Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J (1997) 2.97
Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol (1981) 2.38
Current "corrected" calcium concept challenged. Br Med J (1975) 1.66
Biguanides and lactic acidosis. Br Med J (1977) 1.59
Assessment of a simple colorimetric procedure to determine smoking status in diabetic subjects. Clin Chem (1994) 1.41
Osteoporosis screening in people with airways disease. Chron Respir Dis (2005) 1.41
Hypertension and diabetes in older people. Med J Aust (1993) 1.38
Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem (1993) 1.32
Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol. Br J Clin Pharmacol (1980) 1.30
Adaptation in patterns of c-fos expression in the brain associated with exposure to either single or repeated social stress in male rats. Eur J Neurosci (1998) 1.24
Interpretation of glucose tolerance tests. Med J Aust (1980) 1.23
Variability of urinary albumin excretion in patients with microalbuminuria. Diabetes Care (1994) 1.21
Current "corrected" calcium concept rechallenged. Clin Chem (1977) 1.16
Cytochrome P450-dependent metabolism of gefitinib. Xenobiotica (2005) 1.14
Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int (1998) 1.10
Simulation of animal cell metabolism. Cytotechnology (1992) 1.09
The clinical role of quantitative ultrasound in assessing fracture risk and bone status. Med J Aust (2000) 1.08
Screening for diabetic retinopathy. Med J Aust (1995) 1.07
Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole. J Clin Invest (1991) 1.06
Metabolism of Casodex in laboratory animals. Xenobiotica (1993) 0.99
The increasing prevalence of diabetes in South Australia: the relationship with population ageing and obesity. Public Health (2006) 0.97
Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J Clin Endocrinol Metab (2001) 0.95
Capillary blood glucose measurements in hospital inpatients using portable glucose meters. Aust N Z J Med (1993) 0.91
Urinary free corticosteroid excretion and renal function. J Clin Pathol (1978) 0.91
Metformin associated lactic acidosis. Aust N Z J Med (1978) 0.90
Reduction of cerebrospinal fluid phenylalanine after oral administration of valine, isoleucine, and leucine. Pediatr Res (1982) 0.90
Hypercalcaemia associated with tuberculosis. Br Med J (1980) 0.87
Web space sinus in a shearer. Med J Aust (1966) 0.86
Compartmental shift of potassium--a result of sympathomimetic overdose. Aust N Z J Med (1978) 0.86
Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy. Aust N Z J Med (1977) 0.86
Metabolism and enantioselective pharmacokinetics of Casodex in man. Xenobiotica (1993) 0.86
Components of total measurement error for hemoglobin A(1c) determination. Clin Chem (2001) 0.83
Pulmonary tuberculosis and hypercalcaemia. Ann Intern Med (1979) 0.83
Randomized controlled trial of alendronate in airways disease and low bone mineral density. Chron Respir Dis (2004) 0.82
Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis. Osteoporos Int (2001) 0.82
Osteoporosis in the community: Sensitivity of self-reported estimates and medication use of those diagnosed with the condition. Bone Joint Res (2012) 0.82
In vitro metabolism of gefitinib in human liver microsomes. Xenobiotica (2005) 0.81
Alpha1-fetoprotein in the diagnosis of hepatoma: statistical and cost benefit aspects. J Clin Pathol (1977) 0.81
Rapid onset of pituitary apoplexy after goserelin implant for prostate cancer: need for heightened awareness. Intern Med J (2001) 0.81
Computational and performance aspects of PCA-based face-recognition algorithms. Perception (2001) 0.81
c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y. Brain Res (1995) 0.80
Traumatic hyphema: a critical review of the scientifically catastrophic history of steroid treatment therefore; and A report of 24 additional cases with no rebleeding after treatment with the Yasuna systemic steroid, no touch PLUS protocol. Binocul Vis Strabismus Q (2000) 0.79
Quantitation of extracts containing tumour angiogenesis factor (TAF) by radioimmunometric and radioimmunoassays. Int J Cancer (1980) 0.79
Letter: Cost of diagnosis of phaeochromocytoma. Med J Aust (1975) 0.78
Enzymatic quantification of 1,5-anhydro-D-glucitol: evaluation and clinical application. Clin Chem (1994) 0.78
Rationalizing the diagnosis of diabetes mellitus. Med J Aust (1977) 0.78
Biosynthesis of protein products by animal cells. Are growth and non-growth associated concepts valid or useful? Cytotechnology (1996) 0.77
Routine real-time scanning at the first hospital visit. Br J Obstet Gynaecol (1982) 0.77
Comparative diagnostic value of phenylalanine challenge and phenylalanine hydroxylase activity in phenylketonuria. Clin Genet (1983) 0.77
PLD1b in IIC9 fibroblasts is selectively activated in the nucleus and not in the Golgi apparatus. Cell Biol Int (2001) 0.77
Screening for microalbuminuria by use of a rapid, low-cost colorimetric assay. Clin Chem (1989) 0.76
Oral hypoglycaemic agents--dangers and contraindications. Med J Aust (1977) 0.76
Familial hypouricaemia associated with renal tubular uricosuria and uric acid calculi: case report. J Clin Pathol (1980) 0.76
Structured modelling of animal cells. Cytotechnology (1996) 0.76
Asthma and chronic obstructive airway diseases are associated with osteoporosis and fractures: a literature review. Respirology (1999) 0.75
Computer based quality assessment of hospital capillary blood glucose monitoring. Diabet Med (1990) 0.75
Hypertension and diabetes in older people. Med J Aust (1994) 0.75
Biguanides and lactic acidosis in diabetics. Br Med J (1978) 0.75
Effective thyroxine ratio and venous stasis. J Clin Pathol (1977) 0.75
Written guidelines for laboratory testing. Crit Care Resusc (2001) 0.75
Racial differences in oral glucose screening test results: establishing race-specific criteria for abnormality in pregnancy. Obstet Gynecol (1993) 0.75
Effect of orally administered beclomethasone dipropionate on calcium absorption from the gut in normal subjects. Thorax (1993) 0.75
Severe hypernatraemia in adults. Br Med J (1979) 0.75
Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J (Clin Res Ed) (1981) 0.75
Corrected calcium conflict continues. J Clin Pathol (1980) 0.75
Iizaka et al. (2011) critique. J Wound Care (2011) 0.75
Dextrostix/Eyetone in the insulin hypoglycaemia test. Br Med J (1977) 0.75
Primary hypothyroidism misdiagnosed as combined hypothalamic hypothyroidism and secondary adrenal insufficiency. Arch Intern Med (1980) 0.75
Transluminal balloon angioplasty in diabetic peripheral vascular disease. Aust N Z J Surg (1987) 0.75
Letter: Thyroid-hormone levels in protein-calorie malnutrition. Lancet (1976) 0.75
Phenformin, tetracycline and lactic acidosis. Ann Intern Med (1977) 0.75
Intravenous calcium salts. Lancet (1980) 0.75
The effect of temperature and humidity on the permeability of film dressings. J Wound Care (2011) 0.75
Benchmarking of electro-optic monitors for femtosecond electron bunches. Phys Rev Lett (2007) 0.75
Re-evaluation of the fructosamine reaction. Clin Chem (1988) 0.75
The metabolic fate of the synthetic prostaglandin cloprostenol ('Estrumate') in the cow: use of ion cluster techniques to facilitate metabolite identification. Biomed Mass Spectrom (1980) 0.75
Dietary compliance in the short bowel syndrome. JPEN J Parenter Enteral Nutr (1984) 0.75
Paracetamol concentrations, hepatotoxicity, and antidotes. Br Med J (1980) 0.75
Letter: Aetiology of hyponatremia. Med J Aust (1976) 0.75
Hyperosmolar non-ketotic diabetic coma -- less sodium in therapy? Anaesth Intensive Care (1980) 0.75
Salbutamol and ketonuria in pregnancy. Case report. Br J Obstet Gynaecol (1980) 0.75
Aqueous-based glucose control solutions for use with glucose reagent-strips and meters. Clin Chem (1989) 0.75
Nutrient intake and the menstrual cycle. Aust N Z J Med (1982) 0.75
Profound hypocalcaemia associated with oestrogen treatment of carcinoma of the prostate. Med J Aust (1983) 0.75
Colorimetric screening method for microalbuminuria: intra-individual variability for untimed day specimens. Clin Chem (1989) 0.75
High density lipoprotein in prediction of coronary heart disease. Med J Aust (1980) 0.75
Case studies in lipid management. Aust Fam Physician (1995) 0.75
The psychological aspects of artificial nutritional support. Aust N Z J Psychiatry (1985) 0.75
Acid-base status and parathyroid hormone in dialysed patients. Lancet (1975) 0.75
Water metabolism. Anaesth Intensive Care (1977) 0.75
Letter: Drug-withdrawal syndromes. Lancet (1976) 0.75
High-energy, ceramic-disk Yb:LuAG laser amplifier. Opt Express (2012) 0.75
Letter: Adjustment of serum calcium for protein. Clin Chem (1976) 0.75
Letter: The pain of venipuncture. N Engl J Med (1976) 0.75
Enteral feeding--a practical approach. Anaesth Intensive Care (1985) 0.75
Alternate site testing for HbA1c using the Primus CLC330 GHb analyzer. Diabetes Care (1997) 0.75
Letter: Thyroid-function tests in diphenylhydantoin-treated patients. Clin Chem (1976) 0.75
Letter: Electrolyte disturbances in beer drinkers. Lancet (1975) 0.75
Letter: Serum-phenytoin levels. Lancet (1975) 0.75
The disposition of tert-butyl-D-serine in the rat. Xenobiotica (1990) 0.75